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doi:10.1016/j.jtcvs.2006.06.009uring the past 10 years, cardiac surgeons have attempted to optimize safety
and operative quality while minimizing patient trauma. The springboard for
minimizing incision size and altering surgical techniques has been the fact
hat arterial obstructions could be treated via a single arterial puncture and a
atheter. Recently, cardiologists foisted the notion that not only is this approach the
east invasive method possible but also that drug-eluting stents are achieving
nirvana” status in curing coronary disease. Similarly, many are convinced that
alvular heart disease can be cured or “well” palliated by percutaneous methods that
nclude stent-mounted aortic valves as well as mitral leaflet “clipping” or annular
stiffening” devices. The rise of these and other technologic “wonders” is causing
ardiac surgeons to re-evaluate our specialty position in the treatment of cardiovas-
ular diseases. We must now look toward innovative endoscopic methods for doing
ome cardiac operations.
Our long-standing interest in living physiology and pathology, our direct access
o cardiac maladies, and our 50 years of experience in following results of curative
ather than palliative cardiac operations have given cardiac surgeons the most
xperience in treating valve disease. These comments are rendered not to discourage
or denigrate the magnificent technologic advances made by our cardiology col-
eagues, because they inspired us to change in many ways. However, there is a
essage and a clarion call for us to develop the least invasive valve operations
ossible.
What am I saying? In this volume of the Journal, Murphy and associates1
escribe what they call an endoscopic robotic mitral valve operation. Their clinical
esults in 127 patients are excellent, despite a reasonably high conversion rate to a
ternotomy (4.7%) and a short follow-up that is incumbent with any new technol-
gy. A closed-chest totally endoscopic mitral repair is the goal that many of us have
ttempted to achieve well before the advent of robotic devices.2 The evolution of
obotic mitral repair has been relatively slow because the Food and Drug Admin-
stration trials were completed in 2001 and the device was approved for intracardiac
se in 2002.3 Our group has achieved similar results to Murphy’s group in over 270
obotic mitral repairs, albeit with no conversions.4 Thus, their confirmation of the
ethod’s safety and efficacy certainly helps to show that surgeons who develop a
eam approach and are dedicated to the technique can deliver the least invasive
ethod for mitral repairs. It is clear from our work and Murphy’s article that the
estination should be truly endoscopic operations, as long as they fulfill the
arameters of quality and safety and can be done by multiple surgeons. As cardiac
urgeons, our destiny will be determined by our willingness and ability to embrace
evices and methods that, heretofore, we never considered.
I envision that the ideal robotic mitral repair would be done endoscopically and
ompletely from the operative console, the reason being that a port incision less than
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Lcm does not facilitate extracorporeal knot tying or other
ardiac manipulation. These operations are not simply ex-
irpative or ablative but fine valve reconstructions. Thus, it
eems incumbent that we perfect methods to reconstruct the
itral valve using only 3-dimensional endoscopic vision
nd telemanipulation via the tiniest incisions or ports. Mur-
hy and colleagues describe their method of tying repair and
trial closure sutures by a patient-side surgeon assistant. I
elieve that true endoscopic robotic operations should in-
lude making the left atriotomy and establishing retraction,
s well as completing valve reconstructions and replace-
ents with associated knot tying, deairing, and atrial clo-
ure done from the operating console. This editorial is no
riticism of the surgical methods described in this article but
s to encourage surgeons who have become interested in
sing new technology, such as robotic telemanipulation, to
ry to become asymptotic to the “least invasive operation.”
hus, methods shown by Murphy’s group and my group
ertainly are not the destination for minimally invasive54 The Journal of Thoracic and Cardiovascular Surgery ● Octonterest and ability in melding the fantastic experiences over
he past 50 years with developing systems of closed chest
isualization, tissue telemanipulation, and operative simu-
ation. Perhaps some day we will even be able to repair
itral valves inside the beating heart using robotics with
chocardiographic guidance. The work that is presented in
his issue of the Journal is merely a stop on the trip and not
he final destination.
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